Local High-Capacity Adenovirus-Mediated mCTLA4Ig and mCD40Ig Expression Prolongs Recombinant Gene Expression in Skeletal Muscle
Open Access
- 30 June 2001
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 3 (6), 892-900
- https://doi.org/10.1006/mthe.2001.0331
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- CTLA4Ig inhibits T cell–dependent B-cell maturation in murine systemic lupus erythematosusJCI Insight, 2000
- Immunomodulation and Adenoviral Gene Transfer to the Lungs of Nonhuman PrimatesHuman Gene Therapy, 2000
- Effective repeat administration with adenovirus vectors to the muscleGene Therapy, 2000
- Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administrationGene Therapy, 1999
- Immune response to green fluorescent protein: implications for gene therapyGene Therapy, 1999
- Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4IgGene Therapy, 1998
- Cyclophosphamide Diminishes Inflammation and Prolongs Transgene Expression Following Delivery of Adenoviral Vectors to Mouse Liver and LungHuman Gene Therapy, 1996
- Prevention of Immune Reactions Triggered by First-Generation Adenoviral Vectors by Monoclonal Antibodies and CTLA4IgHuman Gene Therapy, 1996
- CTLA-4 ligation blocks CD28-dependent T cell activation.The Journal of Experimental Medicine, 1996
- CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.The Journal of Experimental Medicine, 1996